An international research team has discovered a critical protein that acts as a 'switch' regulating immune responses to viruses.

Adam Kovalčík figured out how to make an antiviral drug for a fraction of the normal cost, using an alcohol from corn husks.

The firms launched the global Phase II bladder cancer trial for autogene cevumeran after seeing early success in pancreatic ...

The deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.

Lilly will use Rznomics’ proprietary ribozyme technology to develop RNA editing therapies for congenital hearing loss.

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

Eli Lilly signs a global licensing deal with Rznomics to co-develop RNA-editing therapies for hearing loss, with potential ...

Eli Lilly is building out its gene therapy pipeline for hearing loss through a new deal with RNA-focused startup Rznomics.

EnPlusOne Biosciences, Inc., a biotechnology company pioneering enzymatic solutions for RNA manufacturing, will present new data from its proprietary ezRNA™ platform at TIDES USA, the leading ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies ...

In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment ...